Medical consumables

Tender description

NHS Supply Chain has established a non-exclusive framework agreement for supply to NHS Supply Chain depots via the stock/blue diamond routes and to the NHS Supply Chain customer base via the e-direct route. The framework agreement is for the supply of wound drainage, post-operative and intra-operative autologous blood system products and consumables. The framework agreement has an initial term of 24 months with an option to extend incrementally for up to a total period of 48 months. It is anticipated that in the first 24 months of the framework agreement the value of purchases will be circa 16 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 32 000 000 GBP. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business. Wound drainage products are used in a medical environment to drain excess fluid from a wound to prevent infection and speed up the healing process. These are used post-surgery or after medical procedures and will aid in the healing process. This lot includes, but is not limited to, wound drainage products such as low vacuum wound drainage systems, high vacuum wound drainage systems, passive/gravity wound drainage systems, silicon drains and wound drainage system accessories. It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 5 200 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 10 400 000 GBP. Post-operative autologous blood systems are used for the collection of blood from a single patient to be stored and then re-transfused at a later date. Typically the products are used procedures in advance of surgery which has high blood loss associated like joint replacements or spinal surgery. This lot includes, but is not limited to, post-operative autologous blood system products such as post-operative auto transfusion kits and associated consumables, bottles, blood salvage systems and associated consumables/accessories. It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 1 800 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 3 600 000 GBP. Intra-Operative autologous blood systems are used to clean blood and recover red blood cells during surgery. Once the blood has been washed to remove unwanted blood components, the red blood cells are then reinfused. This lot includes, but is not limited, intra-operative autologous blood system products such as bowls, processing sets, reinfusion bags, reservoirs, sequestration sets, suction lines, suction tubing, waste bags consumables and intra-operative autologous cell salvage blood machines It is anticipated that in the first 24 months of the framework agreement the value of purchases for this lot will be circa 1 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 2 000 000 GBP. Intra-Operative autologous blood systems are used to clean blood and recover red blood cells during surgery. Once the blood has been washed to remove unwanted blood components, the red blood cells are then reinfused. This lot is for set purchase plans of the intra-operative autologous blood system capital systems with captial costs tied into the set usage of intra-operative autologous blood system capital equipment and associated consumables. The range of products that can be supplied under this lot are restricted to the following: — autotransfusion system for intra-operative autologous blood transfusion (capital equipment) set purchase plan with capital cost recovered via associated consumables, — waste bags, — fluid collection bags, — autotransfusion collection reservoir, — bowl Set 71 ml — 125 ml, — aspiration and anticoagulation line set, — filtered vacuum line. It is anticipated that in the first 24 months of the framework agreement the value of purchases for this Lot will be circa 8 000 000 GBP. For the full 48 month term (if extended) the anticipated value is circa 16 000 000 GBP.